期刊
PATHOGENS
卷 11, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/pathogens11010027
关键词
DFTD; laboratory diagnosis; transmissible cancer; histopathology; proteomics; bioinformatics; extracellular vesicles
类别
资金
- University of Tasmania Foundation: Funds raised by the Save the Tasmanian Devil Appeal [DP130100715, DE180100484, DP180100520]
- National Geographic Explorer: Early Career Grant
- Holsworth Wildlife Research Endowment [L0025447]
- Wildcare Inc.
- Australian Research Council [DE180100484] Funding Source: Australian Research Council
Devil Facial Tumour Disease (DFTD) is a new infectious disease that has improved diagnostic techniques through the generation of disease-specific knowledge. Research has identified the cancerous characteristics and molecular mechanisms of this disease, leading to the development of various diagnostic methods for early detection and diagnosis.
Devil Facial Tumour Disease (DFTD) is an emerging infectious disease that provides an excellent example of how diagnostic techniques improve as disease-specific knowledge is generated. DFTD manifests as tumour masses on the faces of Tasmanian devils, first noticed in 1996. As DFTD became more prevalent among devils, karyotyping of the lesions and their devil hosts demonstrated that DFTD was a transmissible cancer. The subsequent routine diagnosis relied on microscopy and histology to characterise the facial lesions as cancer cells. Combined with immunohistochemistry, these techniques characterised the devil facial tumours as sarcomas of neuroectodermal origin. More sophisticated molecular methods identified the origin of DFTD as a Schwann cell, leading to the Schwann cell-specific protein periaxin to discriminate DFTD from other facial lesions. After the discovery of a second facial cancer (DFT2), cytogenetics and the absence of periaxin expression confirmed the independence of the new cancer from DFT1 (the original DFTD). Molecular studies of the two DFTDs led to the development of a PCR assay to differentially diagnose the cancers. Proteomics and transcriptomic studies identified different cell phenotypes among the two DFTD cell lines. Phenotypic differences were also reflected in proteomics studies of extracellular vesicles (EVs), which yielded an early diagnostic marker that could detect DFTD in its latent stage from serum samples. A mesenchymal marker was also identified that could serve as a serum-based differential diagnostic. The emergence of two transmissible cancers in one species has provided an ideal opportunity to better understand transmissible cancers, demonstrating how fundamental research can be translated into applicable and routine diagnostic techniques.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据